200,000+ products from a single source!
sales@angenechem.com
84661-50-7 | 4-Isoxazolecarboxylicacid, 5-amino-3-methyl-
CAS No: 84661-50-7 Catalog No: AG0050F1 MDL No:MFCD03820629
Product Description
Catalog Number:
AG0050F1
Chemical Name:
4-Isoxazolecarboxylicacid, 5-amino-3-methyl-
CAS Number:
84661-50-7
Molecular Formula:
C5H6N2O3
Molecular Weight:
142.1127
MDL Number:
MFCD03820629
IUPAC Name:
5-amino-3-methyl-1,2-oxazole-4-carboxylic acid
InChI:
InChI=1S/C5H6N2O3/c1-2-3(5(8)9)4(6)10-7-2/h6H2,1H3,(H,8,9)
InChI Key:
CNZBKZVKOBKIOR-UHFFFAOYSA-N
SMILES:
OC(=O)c1c(N)onc1C
Properties
Complexity:
150
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
142.038g/mol
Formal Charge:
0
Heavy Atom Count:
10
Hydrogen Bond Acceptor Count:
5
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
142.114g/mol
Monoisotopic Mass:
142.038g/mol
Rotatable Bond Count:
1
Topological Polar Surface Area:
89.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.5
Literature
| Title | Journal |
|---|---|
| A new class of isoxazole derivatives: the M 1-9 series of compounds with immunotropic activity. | Acta poloniae pharmaceutica 20080101 |
| Synthesis, immunological activity and computational study of 5-amino-3-methyl-4-isoxazolecarboxylic acid semicarbazides and thiosemicarbazides. | Acta poloniae pharmaceutica 20080101 |
| The synthesis, physicochemical properties and immunological activity of 5-amino-3-methylisoxazolo[5,4-d]4-pyrimidinone derivatives. | Cellular & molecular biology letters 20050101 |
| Structure/activity investigations of 5-substituted 3-methylisoxazole[5, 4-d]1, 2, 3-triazin-4-one derivatives. | Archiv der Pharmazie 20040201 |
| Reactions of 5-amino-3-methylisoxazole-4-carboxylic acid hydrazide with carbonyl compounds: immunological activity and QSAR studies of products. | Archiv der Pharmazie 20010301 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.